Final results of phase I trial of HF10, oncolytic virus immunotherapy, in Japanese patients with refractory superficial cancers

Authors
Category Primary study
JournalAnnals of Oncology
Year 2017
This article has no abstract
Epistemonikos ID: 6f1c7d8ed6ed14128b93d229052c3de5ffd39ea1
First added on: Feb 08, 2025